RNA Based Therapeutic Market Impact of Recession in 2023: Industry Share Will Increase at 17.6% CAGR Globally by 2030

According to the report, the global RNA based therapeutics industry was estimated at $4.93 billion in 2021, and is anticipated to hit $25.12 billion by 2030, registering a CAGR of 17.6% from 2021 to 2030.

The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investment regions.

Key Takeaways:

The RNA interference (RNAi) segment, on the other hand, is expected to register the fastest CAGR of 18.8% throughout the forecast period.

Genetic diseases, rare disorders, and molecular diagnostics segment is also projected to manifest the fastest CAGR of 18.2% from 2021 to 2030.

Asia-Pacific region is also expected to cite the fastest CAGR of 18.9% throughout the forecast period.

Request Sample Copy of the Report: 

https://www.alliedmarketresearch.com/request-sample/546

Major Factors Driving the Growth of RNA Based Therapeutics Market:

• Rising prevalence of chronic diseases: Chronic diseases, such as cancer, cardiovascular disease, and neurodegenerative diseases, are on the rise worldwide. RNA-based therapeutics have the potential to treat a wide range of chronic diseases, and this is driving the growth of the market.
• Technological advancements: Technological advancements in RNA biology and delivery technologies are leading to the development of new and more effective RNA-based therapeutics. For example, the development of new RNA delivery technologies is making it possible to deliver RNA-based therapeutics to specific tissues and cells.
• Growing government support: Governments around the world are providing support for the development and commercialization of RNA-based therapeutics. This support is helping to accelerate the growth of the market.
• Increasing investment by private companies: Private companies are also investing heavily in the development and commercialization of RNA-based therapeutics. This investment is helping to drive the growth of the market.
• Rising demand for personalized medicine: There is a growing demand for personalized medicine, which involves developing treatments that are tailored to the individual needs of the patient. RNA-based therapeutics are well-suited for personalized medicine, as they can be programmed to target specific genes and proteins.

Market Segmentation:

By drug class:

• RNA interference (RNAi) therapeutics
• Antisense oligonucleotides (ASOs)
• Messenger RNA (mRNA) therapeutics
• Ribozymes
• Aptamers

By application:

• Oncology
• Infectious diseases
• Rare genetic diseases
• Neurological disorders
• Cardiovascular diseases
• Other

By end user:

• Hospitals
• Clinics
• Ambulatory surgical centers
• Home healthcare

By region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

By technology:

• Lipid nanoparticle (LNP) delivery
• Polymer-based delivery
• Viral vector delivery
• Other delivery technologies

Request for Customization: 

https://www.alliedmarketresearch.com/request-for-customization/546

Regional Growth Dynamics:

The market across North America dominated in 2020, garnering more than two-fifths the global RNA based therapeutics market. High expenditure on R&D, presence of major players & their product availability, and well-established healthcare infrastructure in the region propel the market growth. Simultaneously, the Asia-Pacific region is also expected to cite the fastest CAGR of 18.9% throughout the forecast period. This is attributed to improvements in R&D facilities, available disposable income, and rapidly developing economic conditions.

Key players in the industry:

• Silence Therapeutics plc.
• Arbutus Biopharma Corporation
• Ionis Pharmaceuticals
• Sarepta Therapeutics
• Alnylam Pharmaceuticals, Inc.
• Benitec Biopharma Inc.
• Genzyme (Sanofi), Arrowhead Pharmaceuticals
• Biogen, Inc.
• Gradalis, Inc.

Table of Content:

CHAPTER 1- INTRODUTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Key Players
1.5.Research methodology

1.5.1.Secondary research
1.5.2.Primary research
1.5.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies…….

Buy this Premium Research Report: 

https://www.alliedmarketresearch.com/purchase-enquiry/546

Key Questions Answered in the Intelligent Study

What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the market growth?
What are the key technological and market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?

Why Choose Allied Market Research?

Industries’ Best Analysts
Exclusive Product Offerings
Customer Research Services
Dynamics Research Methodology
Comprehensive Reports
Latest Technological Advancements
Value Chain Analysis
Future Market Opportunities
Market Growth Dynamics
Quality Assurance
Post-sales Support
Continuous Report Update

Market Dynamics and Transformations

Economic Downturn Analysis: Impact of Recession in 2023
Pandemic’s Influence: Impact of Covid-19 Pandemic
Market Evolution: Recent Developments in the Market with Key Players Announcements

Similar Research Reports for Information, Communication and Technology:

Intravenous Immunoglobulin Market – Global Opportunity Analysis and Industry Forecast, 2021–2030

Liver Disease Treatment Market – Global Opportunity Analysis and Industry Forecast, 2021–2030

Ostomy Drainage Bags Market – Global Opportunity Analysis and Industry Forecast, 2021–2030

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com 
Web: https://www.alliedmarketresearch.com  
Follow Us on: LinkedIn Twitter